InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Kaye Randall. Director active across 1 company, notably Longboard Pharmaceuticals, Inc.. Aggregated, 6 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 8 February 2024. The latest transaction was disclosed on 2 December 2024 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Kaye Randall is a declarant linked to Longboard Pharmaceuticals, Inc. She has 6 filings in total, and in the recent filings observed, the buy amount is EUR 2281 with no sales, over the period from 2024-02-09 to 2024-12-02. The most frequent transaction nature is option exercise.